Delivery Order SPE2DB22D3016-SPE2DB24FBBG1

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,247.48 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp. for the supply of 4,565,469,507 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies to support various military treatment...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract is valued at $8,139.82 and has a completion date of September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,874.12 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,144,293 units of Ondansetron ODT 4 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the...
This $2,937.13 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,881,074 units of the drug Ondansetron ODT 4 mg tablets in 30-count packages. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $12,576.93 and a performance period through April 15, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to provide a comprehensive range of...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $18,770.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,604,432 units of ondansetron ODT 4 mg tablets. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a Firm Fixed Price Delivery Order contract worth $18,902.31 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,957,793 units of Ondansetron ODT 4 mg tablets in 30-count packages, with a period of performance through March 14, 2024. This delivery order is issued under an Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $4,095.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4,563,943,300 Ondansetron ODT 4 mg tablets. The delivery order is valued at $2,256.20 and has a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,028,975 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The delivery order, valued at $12,140.16, has a period of performance ending on March 21, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, with a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBBG1
    Delivery Order

The Defense Logistics Agency (DLA) Troop Support Medical awarded a $20,852.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the provision of 4,565,177,802 units of ondansetron ODT 8 mg tablets. The contract has a period of performance through July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/16/24, 9:17 AM